A phase 3 clinical trial shows that a blood test can predict response to treatment for metastatic prostate cancer.

Researchers have developed a test that could detect colorectal cancer with 83 per cent accuracy using a simple blood sample, ...

A new blood-based test for colorectal cancer currently up for FDA review could mean cheaper and less invasive screenings for the disease. Doctors and advocates have been waiting for years for a ...

Prostate Cancer UK says men at highest risk should be told that they can request a blood test to look for signs of the ...

New research shows that an easy blood test could help doctors decide on the best way to treat patients with advanced prostate ...

Experimental blood test shows promise in detecting pancreatic cancer earlier, offering new hope for timely treatment and ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which ...

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters. The findings pave the way for further ...

The non-invasive test, which measures circulating tumor cells in the blood, can predict treatment response, disease ...

A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes ... detect cancers with high accuracy. Our results show that that this combined approach has higher ...

For adults with average cancer risk, a blood test could provide an option for colon cancer screening instead of a colonoscopy. The Food and Drug Administration has approved a blood test ...